|
DHX29 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.782800E-04 |
| Normal-vs-Stage3 |
6.82787160144471E-14 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.164300E-02 |
| Stage1-vs-Stage3 |
4.911000E-01 |
| Stage1-vs-Stage4 |
1.564940E-03 |
| Stage2-vs-Stage3 |
1.338390E-02 |
| Stage2-vs-Stage4 |
1.848110E-04 |
| Stage3-vs-Stage4 |
4.056300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.64989999998466E-06 |
| Normal-vs-Asian |
1.63025148935958E-12 |
| Caucasian-vs-AfricanAmerican |
3.209600E-01 |
| Caucasian-vs-Asian |
1.806240E-01 |
| AfricanAmerican-vs-Asian |
1.040790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18194343201594E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
7.940000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
3.61044527608101E-13 |
| Normal-vs-Age(61-80Yrs) |
8.49440517924904E-11 |
| Normal-vs-Age(81-100Yrs) |
1.539650E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.948800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.655410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.789200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.311000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.873800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.658600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.409400E-04 |
| Classical-VS-Follicular |
1.223910E-03 |
| Classical-VS-Other |
3.233400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
8.90629999750203E-08 |
| Tall-VS-Other |
6.956800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.428400E-02 |
| Follicular-VS-Normal |
4.5121999999731E-06 |
| Other-VS-Normal |
1.73020999999496E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11120002088683E-11 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.82620000000511E-05 |
|
|
